Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1985 Dec;20(6):699–702. doi: 10.1111/j.1365-2125.1985.tb05133.x

Pharmacokinetics of ranitidine in acute upper gastrointestinal haemorrhage.

O Varoquaux, J M Trawale, J Doll, J Andrieu, S Grosbuis, M Pays, C Advenier
PMCID: PMC1400845  PMID: 3879183

Abstract

A pharmacokinetic study of ranitidine was performed in 14 patients with haematemesis divided into two groups according to the severity of blood loss. Pharmacokinetic values were calculated from plasma concentrations after the first of three daily injections (100 mg) and compared with those obtained in five healthy volunteers (50 mg i.v.). There were no significant differences between patients in the two haemorrhage groups and controls. The low, or even questionable, effectiveness of histamine H2-receptor antagonists in the treatment of upper gastrointestinal haemorrhage does not seem to be due to pharmacokinetic factors.

Full text

PDF
699

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barer D., Ogilvie A., Henry D., Dronfield M., Coggon D., French S., Ellis S., Atkinson M., Langman M. Cimetidine and tranexamic acid in the treatment of acute upper-gastrointestinal-tract bleeding. N Engl J Med. 1983 Jun 30;308(26):1571–1575. doi: 10.1056/NEJM198306303082606. [DOI] [PubMed] [Google Scholar]
  2. Coraggio F., Scarpato P., Spina M., Lombardi S. Somatostatin and ranitidine in the control of iatrogenic haemorrhage of the upper gastrointestinal tract. Br Med J (Clin Res Ed) 1984 Jul 28;289(6439):224–224. doi: 10.1136/bmj.289.6439.224. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Dawson J., Cockel R. Ranitidine in acute upper gastrointestinal haemorrhage. Br Med J (Clin Res Ed) 1982 Aug 14;285(6340):476–477. doi: 10.1136/bmj.285.6340.476. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Holloway R. H., Kuljian B., Eshelman F., McCallum R. W. Effects of ranitidine and of cimetidine on pentagastrin-stimulated gastric acid secretion. Clin Pharmacol Ther. 1984 Feb;35(2):203–207. doi: 10.1038/clpt.1984.27. [DOI] [PubMed] [Google Scholar]
  5. Lebert P. A., MacLeod S. M., Mahon W. A., Soldin S. J., Vandenberghe H. M. Ranitidine kinetics and dynamics. I. Oral dose studies. Clin Pharmacol Ther. 1981 Oct;30(4):539–544. doi: 10.1038/clpt.1981.200. [DOI] [PubMed] [Google Scholar]
  6. McNeil J. J., Mihaly G. W., Anderson A., Marshall A. W., Smallwood R. A., Louis W. J. Pharmacokinetics of the H2- receptor antagonist ranitidine in man. Br J Clin Pharmacol. 1981 Sep;12(3):411–415. doi: 10.1111/j.1365-2125.1981.tb01236.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Roberts C. J. Clinical pharmacokinetics of ranitidine. Clin Pharmacokinet. 1984 May-Jun;9(3):211–221. doi: 10.2165/00003088-198409030-00003. [DOI] [PubMed] [Google Scholar]
  8. Thomson A. B., Maguire T., Wensel R. H., Sherbaniuk R. W., Bailey R. J., Kirdeikis P. Ranitidine versus cimetidine in the management of acute upper gastrointestinal tract bleeding. J Clin Gastroenterol. 1984 Aug;6(4):295–299. [PubMed] [Google Scholar]
  9. Wilkinson G. R. Pharmacokinetics of drug disposition: hemodynamic considerations. Annu Rev Pharmacol. 1975;15:11–27. doi: 10.1146/annurev.pa.15.040175.000303. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES